Pulse Biosciences, Inc.
PLSE
$25.79
$1.425.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -23.78% | -35.82% | -61.99% | -54.54% | -41.59% |
| Total Depreciation and Amortization | -10.24% | -9.08% | -8.03% | -5.25% | -3.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.67% | 57.66% | 141.21% | 143.68% | 132.23% |
| Change in Net Operating Assets | -506.99% | -441.90% | -20.69% | 134.38% | 109.64% |
| Cash from Operations | -37.70% | -48.92% | -42.76% | -25.54% | -10.57% |
| Capital Expenditure | -83.64% | -152.00% | -128.70% | -139.00% | -89.66% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -95.76% | -168.00% | -146.09% | -159.00% | -89.66% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -96.30% | -84.47% | 3.29% | 8,080.16% | 670.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 79.72% | -- | 73.42% | 98.92% | -4,583.33% |
| Cash from Financing | -96.34% | -84.43% | 3.56% | 4,073.34% | 627.84% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -160.38% | -150.63% | -43.52% | 346.24% | 539.25% |